These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 16513459

  • 1. Long-term study of intraocular pressure changes in patients with human immunodeficiency virus treated with highly active antiretroviral therapy.
    Kozak I, LaBree L, Azen SP, Cheng L, Reagan NL, Freeman WR.
    Ophthalmology; 2006 Mar; 113(3):451-5. PubMed ID: 16513459
    [Abstract] [Full Text] [Related]

  • 2. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000 Mar; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 3. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
    Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA, Studies of Ocular Complications of AIDS Researh Group.
    Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
    [Abstract] [Full Text] [Related]

  • 4. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK.
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment.
    Stone SF, Price P, Tay-Kearney ML, French MA.
    J Infect Dis; 2002 Jun 15; 185(12):1813-7. PubMed ID: 12085331
    [Abstract] [Full Text] [Related]

  • 6. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
    Kuo IC, Kempen JH, Dunn JP, Vogelsang G, Jabs DA.
    Am J Ophthalmol; 2004 Sep 15; 138(3):338-46. PubMed ID: 15364214
    [Abstract] [Full Text] [Related]

  • 7. Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Kunavisarut P, Bijlsma WR, Pathanapitoon K, Patikulsila D, Choovuthayakorn J, Rothova A.
    Am J Ophthalmol; 2010 Aug 15; 150(2):218-22. PubMed ID: 20525529
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
    Lin YC, Yang CH, Lin CP, Yang CM, Chen MS, Chen MY, Sheng WH, Hung CC, Chang SC.
    Ocul Immunol Inflamm; 2008 Aug 15; 16(3):83-7. PubMed ID: 18569793
    [Abstract] [Full Text] [Related]

  • 9. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2006 Aug 15; 113(8):1432-40. PubMed ID: 16766032
    [Abstract] [Full Text] [Related]

  • 10. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD, Keruly JC.
    Clin Infect Dis; 2007 Feb 01; 44(3):441-6. PubMed ID: 17205456
    [Abstract] [Full Text] [Related]

  • 11. Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs.
    Le Moing V, Thiébaut R, Chêne G, Sobel A, Massip P, Collin F, Meyohas M, Al Kaïed F, Leport C, Raffi F, ANRS CO8 (APROCO/COPILOTE) Study Group.
    HIV Med; 2007 Apr 01; 8(3):156-63. PubMed ID: 17461859
    [Abstract] [Full Text] [Related]

  • 12. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C, Lee S, Wong Kh, Cheng L, Lam M.
    HIV Med; 2007 Apr 01; 8(3):181-5. PubMed ID: 17461862
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M, Keane N, McKinnon E, Phung S, Price P.
    HIV Med; 2007 Apr 01; 8(3):148-55. PubMed ID: 17461858
    [Abstract] [Full Text] [Related]

  • 14. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
    Sungkanuparph S, Chakriyanuyok T, Butthum B.
    J Infect; 2008 Jan 01; 56(1):40-3. PubMed ID: 18037166
    [Abstract] [Full Text] [Related]

  • 15. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C, Lapadula G, Barreiro P, Soriano V, Mandalia S, De Silvestri A, Suter F, Maggiolo F, Antinori A, Antonucci F, Maserati R, El Hamad I, Pierotti P, Sighinolfi L, Migliorino G, Ladisa N, Carosi G, Italian MASTER Cohort.
    J Antimicrob Chemother; 2007 Jun 01; 59(6):1141-7. PubMed ID: 17434879
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan 01; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

  • 17. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Horberg MA, Hurley LB, Klein DB, Follansbee SE, Quesenberry C, Flamm JA, Green GM, Luu T.
    Arch Surg; 2006 Dec 01; 141(12):1238-45. PubMed ID: 17178967
    [Abstract] [Full Text] [Related]

  • 18. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2006 Aug 01; 113(8):1441-5. PubMed ID: 16781775
    [Abstract] [Full Text] [Related]

  • 19. The prognosis of CMV retinitis among patients with AIDS in Serbia.
    Dujić M, Jevtović Dj, Salemović D, Ranin J, Brmbolić B, Djurković-Djaković O.
    Biomed Pharmacother; 2008 Sep 01; 62(7):443-7. PubMed ID: 18243635
    [Abstract] [Full Text] [Related]

  • 20. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B, Lisić M, Kniewald T, Ugrinović N, Begovac J.
    Lijec Vjesn; 2005 Sep 01; 127(5-6):123-8. PubMed ID: 16281473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.